SCHEMBL22490888

SCHEMBL22490888

CC(C)(C)[Si](C)(C)OCC(O)[C@H]1O[C@H](O)[C@H](OC(=O)c2ccc(OCc3ccccc3)cc2)[C@@H](O)[C@H]1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46
MAOB P27338 1/20 0.39
NR4A2 P43354 2/20 0.38
NR4A1 P22736 1/20 0.38
NR4A3 Q92570 1/20 0.38
HIF1A Q16665 1/20 0.37
PARP10 Q53GL7 1/20 0.36
SRD5A2 P31213 1/20 0.36
PPARG P37231 1/20 0.36
PRKCA P17252 1/20 0.36
PRKCD Q05655 1/20 0.36
CHRNB2 P17787 1/20 0.35
CHRNA5 P30532 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
EGFR P00533 3/20 0.35
PLA2G4B P0C869 1/20 0.35
RXRA P19793 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22490885 0.82 ADRB2 (0.41) ADRB2ADRB1ADRB3MAOBNR4A2
SCHEMBL23488116 0.77 ADRB2 (0.41) ADRB2ADRB1ADRB3MAOBNR4A2
SCHEMBL15558119 0.70 ADRB2 (0.49) ADRB2ADRB1ADRB3MAOBALDH1A1
SCHEMBL22490919 0.69 LGALS3 (0.50) MAOBNR4A2NR4A1NR4A3HIF1A
SCHEMBL22490855 0.69 LGALS3 (0.50) MAOBNR4A2NR4A1NR4A3HIF1A
SCHEMBL22490926 0.69 LGALS3 (0.50) MAOBNR4A2NR4A1NR4A3HIF1A
SCHEMBL23488416 0.69 LGALS9 (0.49) MAOBNR4A2NR4A1NR4A3HIF1A
SCHEMBL23488692 0.69 MAOB (0.47) MAOBNR4A2NR4A1NR4A3HIF1A
SCHEMBL23488462 0.68 ALDH1A1 (0.40) ADRB2ADRB1ADRB3MAOBNR4A2
SCHEMBL23488417 0.68 LGALS8 (0.53) MAOBNR4A2NR4A1NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed
EP-3717463-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN Sanofi (FR) 2020-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 ADRB2 2675/4885ADRB1 2217/4885ADRB3 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.